Categories: aggregated

Buy! Sell! Puff, Puff, Pass! – Wall Street Drops Drug Testing for Cannabis, What It Could Mean for Your 401k

This trend among Wall Street institutions reflects a broader reevaluation of cannabis nationwide, influenced by its legal status in multiple U.S. states and evolving public sentiment. The shift is driven in part by practical considerations, such as the difficulty of enforcing stringent drug-free policies in areas where cannabis is legal and the necessity of attracting top talent in a competitive job market.

Jason

Share
Published by
Jason

Recent Posts

In Germany’s Cannabis Clubs, You Smoke Alone

Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…

5 hours ago

The Real Wacky Tobacky: Scientists Rewire Tobacco Plant to Make Psychedelics

The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…

5 hours ago

‘Addiction Factory’: Study Denounces the Dangers of Overdiagnosing Habits

The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…

5 hours ago

Most Americans Want Marijuana Legalized. What They Got Was Schedule III

Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…

5 hours ago

Marijuana Reclassification Explained: What the Trump Administration’s Schedule 3 Move Actually Means

On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…

5 hours ago

420 Consciousness and the War Machine – When Opposites Collide

Here we are in 2026, and a conflict that was supposed to wrap up in…

5 hours ago